Enrolment and logistical challenges in TaMoVac 01 Phase I/II HIV trial despite the completion of an earlier (HIVIS-03 trial trial) in Dar es Salaam

por Ngatoluwa, M, Munseri, P, Janabi, M, Mhalu, F, Sandstrom, E, Bakari, M
Publicado 2012

Motivations to participate in a Phase I/II HIV vaccine trial: A descriptive study from Dar es Salaam, Tanzania

por Tarimo, E. A. M., Bakari, M., Kakoko, D. C. V., Kohi, T. W., Mhalu, F., Sandstrom, E., Kulane, A.
Publicado 2016

P14-03. HIV-specific T-lymphocyte proliferative responses induced by a multigene multiclade HIV-1 DNA/MVA heterologous vaccine in Tanzanian volunteers

por Aboud, S, Mhalu, F, Bakari, M, Lifson, J, Lyamuya, E, Marovich, M, Cox, J, Sandstrom, E, Biberfeld, G, Nilsson, C
Publicado 2009

High prevalence of ECG variations and abnormalities in young and healthy TaMoVac 01 HIV vaccine trial volunteers from Tanzania

por Mann, PJ, Munseri, P, Kaluwa, B, Missanga, M, Lwakatare, J, Hoelscher, M, Bakari, M, Janabi, M, Maboko, L, Sandström, E, Kroidl, A
Publicado 2012

P14-14 LB. A low dose of multigene, multiclade HIV DNA given intradermally induces strong and broad immune responses after boosting with heterologous HIV MVA

por Bakari, M, Aboud, S, Nilsson, C, Francis, J, Buma, D, Moshiro, C, Aris, EA, Lyamuya, E, Janabi, M, Mbwana, J, Mwanyika, L, Stout, R, Hejdeman, B, Brave, A, Robb, M, Marovich, M, Michael, N, Earl, P, Moss, B, Wahren, B, Biberfeld, G, Pallangyo, K, Mhalu, F, Sandstrom, E
Publicado 2009

Preferential targeting of conserved Gag regions after vaccination with a heterologous DNA prime Modified Vaccinia Ankara boost HIV vaccine regime

por Bauer, A, Podola, L, Haule, A, Sudi, L, Nilsson, C, Mann, P, Missanga, M, Kaluwa, B, Maboko, L, Lueer, C, Mwakatima, M, Aboud, S, Bakari, M, Currier, J, Robb, M, Joseph, S, McCormack, S, Lyamuya, E, Wahren, B, Sandström, E, Biberfeld, G, Hoelscher, M, Kroidl, A, Geldmacher, C
Publicado 2012

Population Pharmacokinetics of Antimalarial Naphthoquine in Combination with Artemisinin in Tanzanian Children and Adults: Dose Optimization

por Ali, Ali Mohamed, Gausi, Kamunkhwala, Jongo, Said A., Kassim, Kamaka R., Mkindi, Catherine, Simon, Beatus, Mtoro, Ali T., Juma, Omar A., Lweno, Omar N., Gwandu, Conrad H., Bakari, Bakari M., Mbaga, Thabiti A., Milando, Florence A., Hamad, Ali, Shekalaghe, Seif A., Abdulla, Salim, Denti, Paolo, Penny, Melissa A.
Publicado 2022

Breadth, phenotype and functionality of Gag-specific T cell responses induced by a heterologous DNA/MVA prime-boost HIV-1 vaccine regimen

por Podola, L, Bauer, A, Haule, A, Sudi, L, Nilsson, C, Godoy-Ramirez, K, Mann, P, Missanga, M, Kaluwa, B, Maboko, L, Lueer, C, Mwakatima, M, Aboud, S, Bakari, M, Currier, J, Robb, M, McCormack, S, Joseph, S, Lyamuya, E, Hoelscher, M, Wahren, B, Sandström, E, Biberfeld, G, Geldmacher, C, Kroidl, A
Publicado 2012

Priming with a “simplified regimen” of HIV-1 DNA vaccine is as good as a “standard regimen” when boosted with heterologous HIV-1 MVA vaccine

por Munseri, P, Kroidl, A, Nilsson, C, Moshiro, C, Aboud, S, Joachim, A, Geldmacher, C, Aris, E, Buma, D, Lyamuya, E, Gotch, F, Godoy-Ramirez, K, Pallangyo, K, Maboko, L, Marovich, M, Robb, M, Hoelscher, M, Janabi, M, Mann, P, Joseph, S, Mfinanga, S, Stoehr, W, Mhalu, F, Wahren, B, Biberfeld, G, McCormack, S, Sandstrom, E, Bakari, M
Publicado 2012

Safety, Immunogenicity, and Protective Efficacy against Controlled Human Malaria Infection of Plasmodium falciparum Sporozoite Vaccine in Tanzanian Adults

por Jongo, Said A., Shekalaghe, Seif A., Church, L. W. Preston, Ruben, Adam J., Schindler, Tobias, Zenklusen, Isabelle, Rutishauser, Tobias, Rothen, Julian, Tumbo, Anneth, Mkindi, Catherine, Mpina, Maximillian, Mtoro, Ali T., Ishizuka, Andrew S., Kassim, Kamaka Ramadhani, Milando, Florence A., Qassim, Munira, Juma, Omar A., Mwakasungula, Solomon, Simon, Beatus, James, Eric R., Abebe, Yonas, KC, Natasha, Chakravarty, Sumana, Saverino, Elizabeth, Bakari, Bakari M., Billingsley, Peter F., Seder, Robert A., Daubenberger, Claudia, Sim, B. Kim Lee, Richie, Thomas L., Tanner, Marcel, Abdulla, Salim, Hoffman, Stephen L.
Publicado 2018

Safety and Differential Antibody and T-Cell Responses to the Plasmodium falciparum Sporozoite Malaria Vaccine, PfSPZ Vaccine, by Age in Tanzanian Adults, Adolescents, Children, and...

por Jongo, Said A., Church, L. W. Preston, Mtoro, Ali T., Chakravarty, Sumana, Ruben, Adam J., Swanson, Phillip A., Kassim, Kamaka R., Mpina, Maximillian, Tumbo, Anneth-Mwasi, Milando, Florence A., Qassim, Munira, Juma, Omar A., Bakari, Bakari M., Simon, Beatus, James, Eric R., Abebe, Yonas, KC, Natasha, Saverino, Elizabeth, Gondwe, Linda, Studer, Fabian, Fink, Martina, Cosi, Glenda, El-Khorazaty, Jill, Styers, David, Seder, Robert A., Schindler, Tobias, Billingsley, Peter F., Daubenberger, Claudia, Sim, B. Kim Lee, Tanner, Marcel, Richie, Thomas L., Abdulla, Salim, Hoffman, Stephen L.
Publicado 2019